Home › Compare › EMHTF vs GBDC

EMHTF vs GBDC: Dividend Comparison 2026

EMHTF yields 4938.27% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMHTF wins by $55146348937586.39M in total portfolio value
10 years
EMHTF
EMHTF
● Live price
4938.27%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$55146348937607.24M
Annual income
$53,033,758,961,414,200,000.00
Full EMHTF calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — EMHTF vs GBDC

📍 EMHTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMHTFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMHTF + GBDC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EMHTF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMHTF
Annual income on $10K today (after 15% tax)
$419,753.09/yr
After 10yr DRIP, annual income (after tax)
$45,078,695,117,202,070,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, EMHTF beats the other by $45,078,695,117,188,090,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMHTF + GBDC for your $10,000?

EMHTF: 50%GBDC: 50%
100% GBDC50/50100% EMHTF
Portfolio after 10yr
$27573174468814.05M
Annual income
$26,516,879,480,715,325,000.00/yr
Blended yield
96.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

EMHTF
Analyst Ratings
1
Hold
Consensus: Hold
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMHTF buys
0
GBDC buys
0
No recent congressional trades found for EMHTF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMHTFGBDC
Forward yield4938.27% ✓11.86%
Annual dividend / share$2.00 ✓$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1% ✓
Portfolio after 10y$55146348937607.24M ✓$20.85M
Annual income after 10y$53,033,758,961,414,200,000.00 ✓$16,450,733.83
Total dividends collected$55003355952995.54M ✓$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy

Year-by-year: EMHTF vs GBDC ($10,000, DRIP)

YearEMHTF PortfolioEMHTF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$504,527$493,827.16$12,492$1,791.70+$492.0K → EMHTF
2$23,824,817$23,284,973.37$16,527$3,160.58+$23.81M → EMHTF
3$1,053,123,085$1,027,630,530.32$23,588$5,904.90+$1053.10M → EMHTF
4$43,579,292,978$42,452,451,277.21$37,141$11,901.65+$43579.26M → EMHTF
5$1,688,429,051,261$1,641,799,207,774.13$66,205$26,463.38+$1688428.99M → EMHTF
6$61,254,845,187,941$59,448,226,103,092.12$137,452$66,612.65+$61254845.05M → EMHTF
7$2,081,181,684,947,090$2,015,639,000,595,993.00$342,372$195,298.53+$2081181684.60M → EMHTF
8$66,229,598,087,621,200$64,002,733,684,727,816.00$1,053,292$686,954.33+$66229598086.57M → EMHTF
9$1,974,383,155,320,608,300$1,903,517,485,366,853,600.00$4,111,439$2,984,416.95+$1974383155316.50M → EMHTF
10$55,146,348,937,607,240,000$53,033,758,961,414,200,000.00$20,849,974$16,450,733.83+$55146348937586.39M → EMHTF

EMHTF vs GBDC: Complete Analysis 2026

EMHTF — Stock

Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada. It offers dried cannabis strains, pre-rolled cannabis, oral sprays, nano emulsion shots, and cannabis oil products under the SYNC Wellness, fuse, Emerald, and Souvenir brands. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada. As of November 10, 2022, Emerald Health Therapeutics, Inc. operates as a subsidiary of Skye Bioscience, Inc.

Full EMHTF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this EMHTF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMHTF vs SCHDEMHTF vs JEPIEMHTF vs OEMHTF vs KOEMHTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.